Domo, Inc.
NASDAQ:DOMOSoftware - Application
+$0.43 today
- Market cap
- $155.39M
- Beta
- 1.77
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$1.28
Volume 3.18M
Average 1.39M
DOMO Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Domo, Inc.NASDAQ: DOMO
Operating Margin · Q1 FY2027 · quarter ended Apr 2026
Operating margin widens to -13.8%
Operating margin was -13.8% in Q1 FY2027, up 4.1 pp from a year earlier. On a trailing-twelve-month basis it was -11.2%, up 5.2 pp year over year. Over 3 fiscal years it widened by 16.5 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
- FY2026 was the highest level in the 4 fiscal years shown.
What to watch
Whether operating margin reaches the consensus estimate from 1 analysts of 3.3% for the fiscal year ending Jan 2027, up from -12.3% in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- -13.8%-0.5 pp QoQ
- Last fiscal yearJan 2026
- -12.3%+6.4 pp YoY
- LTMApr 2026
- -11.2%+5.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +4.1 pp | +13.6 pp | +9.5 pp |
| 1 year | +6.4 pp | +15.5 pp | +9.1 pp |
| 3 years | +16.5 pp | +15.7 pp | -0.8 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- -12.3%
- Year-over-year change
- +6.4pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | -12.3% | +6.4pp |
| FY2025 | 2025-01-31 | -18.7% | -1.5pp |
| FY2024 | 2024-01-31 | -17.2% | +11.6pp |
| FY2023 | 2023-01-31 | -28.8% | +5.5pp |
| FY2022 | 2022-01-31 | -34.3% | — |
Operating Margin vs competitors
How DOMO compares with its peers on the latest reported figures
- DOMO's LTM Apr 2026 operating margin of -11.2% is the 7th highest of the 10 companies compared; the peer median is -8.0%.
- Its year-over-year change of +5.2 pp is the 9th highest of 10, against a peer median of +7.6 pp.
- Over three fiscal years its change of +16.5 pp compares with a peer median of +10.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 29.2% | +6.7 pp | +25.4 pp | |
| LTM Mar 2026 | 12.0% | +5.8 pp | -0.9 pp | |
| LTM Mar 2026 | 11.1% | +7.6 pp | -6.5 pp | |
| LTM Mar 2026 | 6.0% | +17.0 pp | -0.9 pp | |
| LTM Mar 2026 | -8.0% | +5.9 pp | +10.9 pp | |
| LTM Mar 2026 | -10.9% | +4.4 pp | +22.9 pp | |
| LTM Apr 2026 | -11.2% | +5.2 pp | +16.5 pp | |
| LTM Mar 2026 | -13.4% | +20.4 pp | +42.7 pp | |
| LTM Mar 2026 | -221.0% | +4762.7 pp | +1069.7 pp | |
| FY2025 | -6636.0% | +1790.6 pp | -5913.7 pp | |
NBPNovaBridge Biosciences | FY2025 | — | — | — |
| Peer median (excluding DOMO) | -8.0% | +7.6 pp | +10.9 pp | |
Competitors are the stored peer set for DOMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 257.96M | 308.65M | 318.99M | 317.04M | 318.86M |
| Cost of Revenue | 67.15M | 73.08M | 75.47M | 80.99M | 79.74M |
| Gross Profit | 190.82M | 235.57M | 243.52M | 236.05M | 239.12M |
| Gross Margin | 74.0% | 76.3% | 76.3% | 74.5% | 75.0% |
| Research & Development | 81.03M | 95.09M | 85.05M | 87.9M | 77.19M |
| Selling, General & Admin | 198.26M | 229.35M | 213.35M | 206.83M | 201.03M |
| Operating Expenses | 279.29M | 324.44M | 298.4M | 295.33M | 278.22M |
| Depreciation & Amortization | 5.36M | 5.29M | 6.62M | 9.24M | 28.75M |
| EBITDA | (83.11M) | (82.96M) | (47.51M) | (51.69M) | (28.84M) |
| EBITDA Margin | -32.2% | -26.9% | -14.9% | -16.3% | -9.0% |
| Operating Income | (88.47M) | (88.87M) | (54.88M) | (59.28M) | (39.1M) |
| Operating Margin | -34.3% | -28.8% | -17.2% | -18.7% | -12.3% |
| Interest Income | 13.4M | 15.5M | 0 | 0 | 0 |
| Interest Expense | 14.1M | 15.5M | 0 | 19.8M | 0 |
| Other Income / Expenses | (14.1M) | (15.5M) | (19.43M) | (21.44M) | (18.49M) |
| Income Before Tax | (102.57M) | (104.37M) | (74.31M) | (80.73M) | (57.58M) |
| Pre-Tax Margin | -39.8% | -33.8% | -23.3% | -25.5% | -18.1% |
| Income Tax Expense | (461K) | 1.18M | 1.26M | 1.21M | 1.76M |
| Net Income | (102.11M) | (105.55M) | (75.57M) | (81.94M) | (59.34M) |
| Net Margin | -39.6% | -34.2% | -23.7% | -25.8% | -18.6% |
| EPS (Basic) | (3.19) | (3.10) | (2.10) | (2.13) | (1.45) |
| EPS (Diluted) | (3.19) | (3.10) | (2.10) | (2.13) | (1.45) |
| Weighted Avg Shares | 32.02M | 34.09M | 36.05M | 38.5M | 40.98M |
| Weighted Avg Shares (Diluted) | 32.02M | 34.09M | 36.05M | 38.5M | 40.98M |
Domo, Inc.
NASDAQ:DOMO
Intrinsic Alpha fair value
Locked
Current Price
$3.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.